← All organizations
Highest phase reached
Phase 4
First clinical trial
Nov 1, 2012Last known activity
Aug 29, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (18 distinct, 10 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (10 own, 0 via acquisition)
Other trials (7 own, 0 via acquisition)
Recent trials (20)
- NCT06529458Lead sponsorN/AAug 29, 2024
- NCT06529458Sponsor investigatorN/AAug 29, 2024
- NCT06630468Lead sponsorN/ADec 1, 2022
- NCT06630468Sponsor investigatorN/ADec 1, 2022
- NCT06254976Lead sponsorN/AJun 1, 2022
- NCT06254976Sponsor investigatorN/AJun 1, 2022
- NCT06225024OfficialN/AMar 15, 2022
- NCT06225024Sponsor investigatorN/AMar 15, 2022
- NCT06225024Lead sponsorN/AMar 15, 2022
- NCT06282640CollaboratorPhase 4Dec 30, 2021
- NCT05417997CollaboratorPhase 3May 29, 2021
- NCT06020794Reponsible party - principal investigatorN/AFeb 1, 2021
- NCT06020794OfficialN/AFeb 1, 2021
- NCT06020794Lead sponsorN/AFeb 1, 2021
- NCT06020794Sponsor investigatorN/AFeb 1, 2021
Details
- Last known activity
- Aug 29, 2024